Cargando…

Circulating Tfh cell and subsets distribution are associated with low‐responsiveness to hepatitis B vaccination

BACKGROUND: An estimated 5–10 % of healthy vaccinees lack adequate antibody response following receipt of a standard three-dose hepatitis B vaccination regimen. The cellular mechanisms responsible for poor immunological responses to hepatitis B vaccine have not been fully elucidated to date. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Mingjuan, Xiong, Yongzhen, Liang, Dongmei, Tang, Hao, Hong, Qian, Liu, Gang, Zeng, Jinmei, Lian, Tingyu, Huang, Jingxiao, Ni, Jindong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015036/
https://www.ncbi.nlm.nih.gov/pubmed/33794763
http://dx.doi.org/10.1186/s10020-021-00290-7
Descripción
Sumario:BACKGROUND: An estimated 5–10 % of healthy vaccinees lack adequate antibody response following receipt of a standard three-dose hepatitis B vaccination regimen. The cellular mechanisms responsible for poor immunological responses to hepatitis B vaccine have not been fully elucidated to date. METHODS: There were 61 low responders and 56 hyper responders involved in our study. Peripheral blood samples were mainly collected at D7, D14 and D28 after revaccinated with a further dose of 20 µg of recombinant hepatitis B vaccine. RESULTS: We found low responders to the hepatitis B vaccine presented lower frequencies of circulating follicular helper T (cTfh) cells, plasmablasts and a profound skewing away from cTfh2 and cTfh17 cells both toward cTfh1 cells. Importantly, the skewing of Tfh cell subsets correlated with IL-21 and protective antibody titers. Based on the key role of microRNAs involved in Tfh cell differentiation, we revealed miR-19b-1 and miR-92a-1 correlated with the cTfh cell subsets distribution and antibody production. CONCLUSIONS: Our findings highlighted a decrease in cTfh cells and specific subset skewing contribute to reduced antibody responses in low responders. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00290-7.